GlassScriptPhysician profile
Allison Turner
NPI 1023456076
$37,102.52
in general payments reported to CMS, 2019-2025
40 companies · $4,973 in 2025
The $4,973 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12K · 2022: $15K · 2023: $3,991 · 2024: $1,256 · 2025: $4,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,858 · Food and Beverage: $3,635 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,550 · Travel and Lodging: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,858.38 |
| Food and Beverage | $3,635.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,550.00 |
| Travel and Lodging | $176.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,149.22 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Omnia Medical, LLC | $11,450.00 | 2021-2022 | |
| Biotronik Nro, INC. | $4,403.48 | 2025 | Prospera |
| Abbott Laboratories | $1,447.65 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $1,430.58 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Spinal Simplicity, LLC | $778.60 | 2022 | |
| Abbvie INC. | $690.81 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $599.52 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $581.09 | 2021-2025 | Belbuca, Xtampza, Nucynta |
| Scilex Pharmaceuticals INC. | $351.13 | 2021-2024 | Ztlido |
| Nevro Corp. | $336.29 | 2021 | |
| Janssen Biotech, INC. | $226.05 | 2021 | |
| Eisai INC. | $149.02 | 2021-2022 | |
| Lilly USA, LLC | $136.51 | 2021-2023 | Emgality |
| Pfizer INC. | $128.79 | 2023-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.